| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| Company: GOG Partners |
| Recipient: You |
| Company: NRG Ovarian Committee Chair |
| Recipient: Your Institution |
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Astellas Medivation |
| Recipient: You |
| Company: CEA |
| Recipient: You |
| Company: Clearity Foundation |
| Recipient: You |
| Company: Haymarket Medical Education |
| Recipient: You |
| Company: IDEOlogy Health |
| Recipient: You |
| Company: Medscape |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Immunogen |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Verastem/Pharmacyclics |
| Recipient: You |
| Company: AADi |
| Recipient: You |
| Company: Caris Life Sciences |
| Recipient: You |
| Company: Iovance Biotherapeutics |
| Recipient: You |
| Company: Janssen Oncology |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
| Company: zentalis |
| Recipient: You |
| Company: Daiichi Sankyo Europe GmbH |
| Recipient: You |
| Company: Novacure |
| Recipient: You |
| Company: BioNTech SE |
| Recipient: You |
| Company: immunocore |
| Recipient: You |
| Company: Sanofi/Aventis |
| Recipient: You |
| Company: seagen |
| Recipient: You |
| Company: Takeda Science Foundation |
| Recipient: You |
| Company: zymeworks |
| Recipient: You |
| Company: profound bio |
| Recipient: You |
| Company: ADC Therapeutics |
| Recipient: You |
| Company: Corcept Therapeutics |
| Recipient: You |
| Company: Third Arc |
| Recipient: You |
| Company: Loxo/Lilly |
| Recipient: You |
| Company: Bristol Myers Squibb Foundation |
| Recipient: You |
| Company: Tango Therapeutics |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: T knife |
| Recipient: You |
| Company: F Hoffman La Roche |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: Xencor |
| Recipient: You |
| Company: Elucida Oncology |
| Recipient: You |
| Company: Tubulis GmbH |
| Recipient: You |
| Company: Clovis Oncology |
| Recipient: You |
| Company: Mersana |
| Recipient: Your Institution |
| Company: Blueprint pharmacetuicals |
| Recipient: Your Institution |
| Company: GSK/Tesaro |
| Recipient: Your Institution |
| Company: Duality Biologics |
| Recipient: Your Institution |
| Company: Schrodinger |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Merck |
| Recipient: Your Institution |
| Company: Regeneron |
| Recipient: Your Institution |
| Company: Verastem |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Immunogen |
| Recipient: Your Institution |
| Company: artios |
| Recipient: Your Institution |
| Company: Amgen |
| Recipient: Your Institution |
| Company: Daiichi Sankyo/Lilly |
| Recipient: Your Institution |
| Company: Immunocore |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| Company: GOG Partners |
| Recipient: Your Institution |
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|